Virtus LifeSci Biotech Cl... (BBC)
NYSEArca: BBC
· Echtzeitkurs · USD
52.39
-2.95 (-5.33%)
Zum Schluss: Aug 31, 2026, 12:09 PM
Virtus LifeSci Biotech Clinical Trials ETF (BBC) ETF-Kurs, Bestände & Analyse
-5.33% (1D)
| Geld | 53.25 |
| Marktkapitalisierung | n/a |
| Fondsvermögen | 46.39 Mio |
| NAV | 55.15 |
| Beta | 1.26 |
| EPS (ttm) | k.A. |
| PE Ratio (ttm) | k.A. |
| Ausstehende Anteile | k.A. |
| Auflagedatum | Dec 16, 2014 |
| Brief | 55.37 |
| Volumen | 18,256 |
| Ø Vol. (20D) | 22,720 |
| Eröffnung | 55.56 |
| Vortagesschluss | 55.34 |
| Tagesspanne | 53.20 - 54.42 |
| 52-Wk Range | 22.82 - 56.18 |
| Positionen | k.A. |
| Kostenquote | 0.65% |
Über BBC
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
Anlageklasse Equity
Tickersymbol BBC
Auflagedatum Dec 16, 2014
Anbieter Virtus
Website Fonds-Homepage
Börse NYSEArca
Top 10 Positionen 11.76% insgesamt
| Name | Symbol | Gewicht |
|---|---|---|
| First Tracks Biother... | TRAX | 1.67% |
| Mbx Biosciences Inc | MBX | 1.24% |
| Ataibeckley Inc | ATAI | 1.23% |
| Monopar Therapeutics... | MNPR | 1.21% |
| Definium Therapeutic... | DFTX | 1.18% |
| Xencor Inc | XNCR | 1.10% |
| Zenas Biopharma Inc | ZBIO | 1.06% |
| Uniqure Nv | QURE | 1.06% |
| Apogee Therapeutics ... | APGE | 1.02% |
| Vor Biopharma Inc Or... | VOR | 0.99% |
Dividenden Dividendenrendite 1.25%
| Ex-Dividende | Betrag | Zahldatum |
|---|---|---|
| Dec 22, 2025 | $0.6550 | k.A. |
| Dec 20, 2024 | $0.2400 | k.A. |
| Dec 20, 2023 | $0.0820 | k.A. |
| Dec 20, 2017 | $0.2970 | k.A. |
| Dec 21, 2015 | $0.1470 | k.A. |
Seite 1 von 2